Posted in | News | Business | Events

TOFWERK Opens in Japan and Korea

TOFWERK is pleased to announce the opening of two new regional offices – TOFWERK Japan and TOFWERK Korea.  

Image Credit: TOFWERK

​​​​​​​East Asia is a rapidly expanding market for TOFWERK, with increasing deliveries of our mass spectrometers for established and emerging applications. Following the successful model of our US and Chinese offices, these new teams and facilities will allow us to directly and efficiently support existing partners and customers, while giving new contacts closer access to our products and technical experts. Our regional teams have already begun to establish productive partnerships with local industrial and academic groups in Japan and Korea to further develop applications and showcase the strengths of TOFWERK technology.

The opening of these offices coincides with the launch of our ClearFab AMC and Process solutions for semiconductor manufacturing – a sector with significant presence in this region. ClearFab AMC Solutions offer comprehensive coverage across all key AMC categories using novel fast-switching time-of-flight chemical ionization mass spectrometry. ClearFab Process Solutions are fully integrated process characterization and monitoring systems.

We invite you to connect to meet our regional staff and to learn more about the advantages of our products.

Source: http://www.tofwerk.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    TOFWERK. (2023, February 09). TOFWERK Opens in Japan and Korea. AZoM. Retrieved on April 25, 2024 from https://www.azom.com/news.aspx?newsID=60829.

  • MLA

    TOFWERK. "TOFWERK Opens in Japan and Korea". AZoM. 25 April 2024. <https://www.azom.com/news.aspx?newsID=60829>.

  • Chicago

    TOFWERK. "TOFWERK Opens in Japan and Korea". AZoM. https://www.azom.com/news.aspx?newsID=60829. (accessed April 25, 2024).

  • Harvard

    TOFWERK. 2023. TOFWERK Opens in Japan and Korea. AZoM, viewed 25 April 2024, https://www.azom.com/news.aspx?newsID=60829.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.